Tuscaloosa Buprenorphine Doctors


Feature Your Practice at the Top of This City Page

Locate Tuscaloosa buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Dr. Leon H Campbell, Jr, M.D.
2720 7th Street
Tuscaloosa, AL 35401
Main Tel: (205) 349-0652
 
 
Dr. Eugene Anthony Mangieri, M.D.
2510 Hospital Drive
P.O. Box 839
Northport, AL 35476
Main Tel: (205) 339-9000
 
 
Dr. John R. Hubbard, M.D., Ph D
Psychiatry South
825 Rice Mine Road North
Tuscaloosa, AL 35406
Main Tel: (205) 764-9844
 
 
Dr. Richard W. Shamblin, M.D.
100 Rice Mine Road
Suite B
Tuscaloosa, AL 35406
Main Tel: (205) 349-4200
 
 
Dr. William Eugene Alldredge, M.D.
100 Rice Mine Road
Tuscaloosa, AL 35406
Main Tel: (205) 349-4200
 
 
Rama D. Pidikiti, M.D.
1321 McFarland Boulevard East
Tuscaloosa, AL 35404
Main Tel: (205) 758-1833
 
 
Dr. M. Omar Mohabbat, M.D.
4804 Highway 69 North
Northport, AL 35473
Main Tel: (205) 330-7700
 
 
Dr. Sanjay K. Singh, M.D.
5690 Watermelon Road
Suite 33
Northport, AL 35473
Main Tel: (205) 554-0866
 
 
Dr. James Fullerton Hooper, IV
1001 Mimosa Park Drive
Tuscaloosa, AL 35405
Main Tel: (205) 752-5857
 
 
Charles Nevels,
1001 Mimosa Park Road
Tuscaloosa, AL 35405
Main Tel: (205) 752-5857
 
 
Dr. Lawrence Roger Lacy, M.D.
3701 Loop Road East
Tuscaloosa, AL 35404
Main Tel: (205) 554-2000
 
 

Sublocade Now Available

Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More

Posted in Buprenorphine, Medication-Assisted Treatment | Tagged | Leave a comment

Ohio Increases Buprenorphine Access

In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More

Posted in Addiction Medications, Buprenorphine, Medication-Assisted Treatment, Suboxone | Tagged , | Leave a comment

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or "Bup", is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

Buprenorphine.US is an information resource for people in search of doctors who specialize in treating opioid addiction with buprenorphine. In recent years, individuals from all age groups and backgrounds have suffered with an unexpected opioid dependency that negatively affected their family relationships, job, finances, and self-esteem. Addiction is a relentless illness, and persistent opiate withdrawal is a particularly difficult medical dilemma. There are presently thousands of U.S. physicians seeking to assist patients ready to address their opioid addiction. Buprenorphine.US is a tool for connecting buprenorphine doctors with new prospective patients wanting specialized primary care for their addictive disorder.